Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -13.20 |
| peg ratio | -0.13 |
| price to book ratio | 0.92 |
| price to sales ratio | 2.53 |
| enterprise value multiple | -11.29 |
| price fair value | 0.92 |
profitability ratios | |
|---|---|
| gross profit margin | 77.44% |
| operating profit margin | -37.66% |
| pretax profit margin | -22.15% |
| net profit margin | -22.15% |
| return on assets | -6.42% |
| return on equity | -7.31% |
| return on capital employed | -11.52% |
liquidity ratio | |
|---|---|
| current ratio | 18.44 |
| quick ratio | 18.44 |
| cash ratio | 5.01 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 16.50 |
| days of payables outstanding | 80.83 |
| cash conversion cycle | -64.33 |
| receivables turnover | 22.12 |
| payables turnover | 4.52 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.94 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.14 |
| cash per share | 4.12 |
| operating cash flow per share | -0.14 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.94 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -69.48 |
Frequently Asked Questions
Fulcrum Therapeutics, Inc. (FULC) published its most recent earnings results on 13-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Fulcrum Therapeutics, Inc. (NASDAQ:FULC)'s trailing twelve months ROE is -7.31%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Fulcrum Therapeutics, Inc. (FULC) currently has a ROA of -6.42%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
FULC reported a profit margin of -22.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 18.44 in the most recent quarter. The quick ratio stood at 18.44, with a Debt/Eq ratio of 0.04.